Mechanisms of propranolol action in infantile hemangioma
Mechanisms of propranolol action in infantile hemangioma
Adverse effects of propranolol when used in the treatment of hemangiomas: A case series of 28 infants - ScienceDirect
JCI - A transcription factor is the target of propranolol treatment in infantile hemangioma
Infantile hemangioma: pathogenesis and mechanisms of action of propranolol - Rotter - 2017 - JDDG: Journal der Deutschen Dermatologischen Gesellschaft - Wiley Online Library
The use of propranolol in the treatment of infantile haemangiomas: an update on potential mechanisms of action - Ji - 2015 - British Journal of Dermatology - Wiley Online Library
Propranolol exhibits activity against hemangiomas independent of beta blockade | npj Precision Oncology
Propranolol inhibits the proliferation, migration and tube formation of hemangioma cells through HIF-1α dependent mechanisms – ScienceOpen
Propranolol Reduces the Development of Lesions and Rescues Barrier Function in Cerebral Cavernous Malformations | Stroke
Identification of putative biomarkers for Infantile Hemangiomas and Propranolol treatment via data integration | Scientific Reports
JCI - Non–beta blocker enantiomers of propranolol and atenolol inhibit vasculogenesis in infantile hemangioma
Molecular mechanism of propranolol in the treatment of hemangiomas. IH,... | Download Scientific Diagram
Management of Head and Neck Hemangiomas in Adults: Oral Propranolol Versus Oral Itraconazole in Conjugation with Injection Sodium Tetra Decyl Sulphate | SpringerLink
Identification of putative biomarkers for Infantile Hemangiomas and Propranolol treatment via data integration | Scientific Reports
Propranolol in the treatment of infantile hemangioma: clinical effectiveness, risks, and recommendations | Actas Dermo-Sifiliográficas
Medical Care hemangioma and complications Dr.F.Iraji. - ppt download
Frontiers | Central Effects of Beta-Blockers May Be Due to Nitric Oxide and Hydrogen Peroxide Release Independently of Their Ability to Cross the Blood-Brain Barrier
Propranolol for treatment of infantile hemangiomas
Enhanced skin delivery of propranolol HCl using nonionic surfactant-based vesicles for topical treatment of infantile hemangioma - ScienceDirect
Propranolol Participates in the Treatment of Infantile Hemangioma by Inhibiting HUVECs Proliferation, Migration, Invasion, and Tube Formation
JCM | Free Full-Text | Propranolol: A “Pick and Roll” Team Player in Benign Tumors and Cancer Therapies
Propranolol therapy for infantile hemangioma: our experience | DDDT
IJMS | Free Full-Text | The Role of Propranolol as a Repurposed Drug in Rare Vascular Diseases
β-adrenergic receptor-dependent and -independent effects of propranolol in infantile hemangioma | Semantic Scholar
Propranolol Therapy for Infantile Hemangioma
